new leaf venture management ii llc  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors new leaf venture management ii llc check out list of companies and businesses related to new leaf venture management ii llc find out new leaf venture management ii llc address and contact details view other people related to new leaf venture management ii llc  coworkers colleagues companions etc address times square tower  times square suite  new york  ny companies related to new leaf venture management ii llc cikcompany namepositioncompany addressworld heart corp wiley post way suite  salt lake city mei pharma inc el camino real suite  san diego irhythm technologies inc townsend street suite  san francisco durata therapeutics inc south wacker drive suite  chicago  new leaf venture management ii llc on the web persons related to new leaf venture management ii llc  world heart corpnamepositioncityabiomed inc owner danversabiomed inc owner danverssrinivas akkarajumenlo parkhove anderssalt lake citymarxe austinsalt lake citysteven r beckerdallasmorgan r brownexec vp and cfo oaklandmorgan r brownexec vp and cfo salt lake citymorgan r brownexecutive vp salt lake citycamber capital management llcbostoncamber capital management llc owner bostonjohn f carlsonst paul mnphilippe chambonnew yorkphilippe chambonnew yorkphilippe o chambonnew yorkgayla j comptonpalo altokevin r comptonpalo altojeani delagardellemenlo parkjeani delagardelledirector salt lake cityjeani delagardelledirector menlo parkjeani delagardelledirector salt lake cityjeani delagardelledirector salt lake citymichael sumner estesdirector oaklandmichael sumner estesdirector salt lake citymichael sumner estesdirector salt lake cityjones eugenesalt lake citywilliam c garriocktoronto on canadawilliam c garriockdirector oaklandwilliam c garriockdirector salt lake citywilliam c garriockdirector salt lake citywilliam c garriockdirector salt lake citygary w goertzdirector oaklandgary w goertzdirector salt lake cityd mark goudievp finance  cfo stittsville on canadaanders d hovedirector new yorkanders d hovedirector palo altoronald huntnew yorkronald huntnew yorkjassawalla jalsalt lake citypiet jansen nl amsterdam netherlandspiet jansenchief medical officer oaklandjal s jassawallapresident  ceo orindajal s jassawallapresident  ceo oaklandjal s jassawallaexec vp and cto oaklandjal s jassawallaexec vp and cto salt lake cityjal s jassawallaexec vp and cto salt lake citydelagardelle jeanisalt lake citymartin johnsalt lake cityeugene b jonesdirector salt lake cityeugene b jonesdirector salt lake citya richard juelisoaklanda richard juelischief financial officer oaklandpratap khanwilkarsalt lake citypratap khanwilkarvp rotary systems and bus dev oaklandpratap khanwilkarvice president oaklandpratap khanwilkarvp rotary systems  bus dev salt lake citykathleen laportemenlo parkvijay k lathimenlo parkvijay k lathimenlo parkrobert j majtelespiedmontrobert j majtelesdirector oaklandjohn marinchakwalnut creekjohn alexander martinceo  president oaklandjohn alexander martinpresident and ceo salt lake cityjohn alexander martinpresident and ceo salt lake cityaustin w marxedirector new yorkaustin w marxedirector salt lake citymarxe austin w  greenhouse david m owner new yorkmarxe austin w  greenhouse david m owner new yorkmaverick venture management llc owner palo altomedquest products incsalt lake citymedquest products inc owner salt lake cityestes michaelsalt lake cityestes phd michaelsalt lake cityphillip millervp research  development berkeleyphillip millervp research  development oaklandphillip millervice president oaklandmichael r minoguesalt lake citybrown morgansalt lake citynew leaf venture associates ii lpnew yorknew leaf venture associates ii lpnew yorknew leaf ventures ii lpnew yorknew leaf ventures ii lp owner new yorkjames niedelnew yorkjames niedelnew yorkdavid pellonechief financial officer oaklandmiller phillipsalt lake citykhanwilkar pratapsalt lake cityc ian rosscollingwood on canadac ian rossdirector oaklandmichael roth owner st francisg stacy smithdallasg stacy smithdallasg stacy smithdallassrb management lpdallasbrian jay starkst francisbrian jay starkst francisjohn j vajdavp manufacturing oaklandjohn j vajdavp manufacturing oaklandvef management v llcpalo altovef management v llcpalo altovenrock associates v lppalo altovenrock associates v lp owner palo altovenrock entrepreneurs fund v lppalo altovenrock entrepreneurs fund v lppalo altovenrock management v llcpalo altovenrock management v llcpalo altovenrock partners management v llcpalo altovenrock partners management v llcpalo altovenrock partners v l ppalo altovenrock partners v l ppalo altopatrick p walkerdallaspatrick p walkerdallaspatrick p walkerdallasreid s walkerdallasreid s walkerdallasreid s walkerdallasreid s walkerdallaswalker smith capital l p owner dallaswalker smith capital qp l pdallaswalker smith international fund ltddallaswalker smith international ltddallaswalker smith international ltddallaswalker smith international ltddallasgarriock williamsalt lake cityjohn woodardsenior vp of scientifc affairs salt lake cityws capital llc owner dallasws capital llc owner dallasws capital management lpdallasws capital management lpdallasws capital management lpdallasws opportunity fund international ltddallasws opportunity fund international ltddallasws opportunity fund international ltddallasws opportunity fund international ltddallasws opportunity fund l pdallasws opportunity fund qp l pdallasws ventures management l pdallasws ventures management l pdallasws ventures management l pdallasmanagement l l c wsvdallasmanagement l l c wsvdallasmanagement l l c wsvdallaspersons related to new leaf venture management ii llc  mei pharma incnamepositioncitysrinivas akkarajumenlo parkjosiah t austin owner dallascharles v baltic iiidirector san diegocharles v baltic iiidirector san diegocharles v baltic iiisan diegocharles v baltic iiidirector san diegocharles v baltic iiisan diegocharles v baltic iiidirector san diegostephen breckenridgenorth ryde nsw williams bryansan diegoleah rush canndirector san diegoleah rush canndirector san diegoleah rush canndirector san diegoleah rush canndirector san diegophilippe chambonsunnyvalephilippe o chambonnew yorkwhite christinesan diegokevan clemensdirector charlottekevan clemensdirector san diegogold danielsan diegokretser david morritz denorth ryde nsw jeani delagardellemenlo parkjeani delagardellemenlo parkbrian g drazbachief financial officer irvineel coronado holdings llcdallasnicholas gloverdirector san diegonicholas gloverdirector san diegonicholas gloverdirector san diegodaniel p phd goldchief executive officer san diego cadaniel p phd goldnew south walesdaniel p phd goldchief executive officer san diegodaniel p phd goldchief executive officer san diegodaniel p phd goldchief executive officer san diegoronald huntnew yorkronald huntnew yorkphilip a johnstonnorth ryde nsw philip a johnstondirector north ryde nswgraham e kellynorth ryde nsw vijay k lathimenlo parkvijay k lathimenlo parkcann leahsan diegorobert d masschief medical officer san diegorobert d masschief medical officer san diegorobert d masschief medical officer san diegochristopher naughtonnorth ryde nsw christopher naughtonceo  president north ryde nswpaul j nestelnorth ryde nsw new leaf venture associates ii lpnew yorknew leaf venture associates ii lpnew yorknew leaf ventures ii lp owner new yorknew leaf ventures ii lp owner new yorkjames niedelnew yorknovogen ltdsydneynovogen ltd owner north ryde nswnovogen ltd owner north ryde nswnovogen ltd owner north ryde nswliam ratcliffenew yorkliam ratcliffenew yorkthomas c reynoldsdirector bothellthomas c reynoldsdirector san diegothomas c reynoldsdirector san diegowilliam dodge rueckertdirector hendersonwilliam dodge rueckertdirector north ryde nswwilliam dodge rueckertdirector san diegowilliam dodge rueckertdirector san diegowilliam dodge rueckertdirector san diegowilliam dodge rueckertdirector san diegodavid r seatonnorth ryde nsw david r seatoncfo  secretary north ryde nswzech thomassan diegodavid m ursosr vp and general counsel san diegodavid m ursosr vp and general counsel san diegovivo ventures fund v lppalo altovivo ventures fund v lppalo altovivo ventures fund vii lppalo altovivo ventures fund vii lppalo altovivo ventures v affiliates fund lppalo altovivo ventures v affiliates fund lppalo altovivo ventures v llc owner palo altovivo ventures v llc owner palo altovivo ventures vii affiliates fund lppalo altovivo ventures vii affiliates fund lppalo altovivo ventures vii affiliates fund lppalo altovivo ventures vii llc owner palo altovivo ventures vii llc owner palo altochristine anna whitedirector san diegochristine anna whitedirector san diegochristine anna whitedirector san diegochristine anna whitedirector san diegorueckert williamsan diegobryan williamsnorth ryde nswbryan williamsdirector north ryde nswbryan williamsdirector san diegobryan williamsdirector san diegothomas m zechchief financial officer new south walesthomas m zechchief financial officer san diegothomas m zechchief financial officer san diegothomas m zechchief financial officer san diegothomas m zechchief financial officer san diegopersons related to new leaf venture management ii llc  irhythm technologies incnamepositioncitytiba aynechisan franciscobruce g bodakendirector san mateode clercq caspersan franciscode clercq caspersan franciscophilippe chambonsunnyvalegrant chrissan franciscojeffrey crowepalo altoclercq casper l dedirector palo altojeani delagardellemenlo parkmatthew c garrettchief financial officer san franciscopromod haquemead hardwinsan franciscomatthew d howardpalo altoronald huntnew yorkmudit k jainportola valleygreen joshuasan franciscogreen joshuasan franciscolenane judithsan franciscoking kevinsan franciscoking kevinsan franciscokevin m kingpresident and ceo santa claravijay k lathidirector menlo parkgarrett matthewsan franciscogoldberg michaelsan franciscogoldberg michaelmenlo parknew leaf venture associates ii lpnew yorknew leaf ventures ii lp owner new yorknorwest venture partners xi lp owner minneapolisnorwest venture partners xii lppalo altoas novo owner bagsvaerdhardwin mead rsan franciscomead rsan franciscoliam ratcliffenew yorkscott raymondsan franciscokatz robertasan franciscokatz robertasan franciscokatz robertasan franciscomark j rubashdirector san josebrasch samsan franciscobrasch samsan franciscoraymond w scottdirector san franciscoguyer shellysan franciscoguyer shellysan franciscoralph snydermandirector richard s stackportola valleywilliam n starling jrpocatellojohnson stevesan franciscoderrick sungsee remarks san franciscosynergy life science partners l p owner portola valleysynergy venture partners llcportola valleyabhijit y talwalkardirector santa claraaynechi tibasan franciscokumar udaysan franciscokumar udaysan franciscolathi vijaysan franciscolathi vijaysan franciscodavid a vortevp sales san franciscowillis williamsan franciscostarling williamsan franciscostarling williamsan franciscostarling williamportola valleywillis williamsan franciscopersons related to new leaf venture management ii llc  durata therapeutics incnamepositioncitybrenton karl ahrensdirector westportbrenton karl ahrensdirector westportaisling capital iii lp owner new yorkaisling capital iii lp owner new yorkaisling capital partners iii llcnew yorkaisling capital partners iii llcnew yorkaisling capital partners iii lpnew yorkaisling capital partners iii lpnew yorksrinivas akkarajumenlo parksrinivas akkarajumenlo parksusan roberta allenmorristownangela gurski birchlermorristownjames c blair owner princetoneric buatoismenlo parkcanaan management incwestportcanaan management incwestportcanaan partners viii llcwestportcanaan partners viii llcwestportcanaan viii lpdirector westportcanaan viii lpdirector westportj martin carrolldirector chicagoj martin carrolldirector chicagophilippe o chambonnew yorkphilippe o chambonnew yorkphilippe o chambonnew yorkschutter richard u dedirector chicagoschutter richard u demorristownschutter richard u dedirector chicagoschutter richard u dedirector chicagojeani delagardellemenlo parkjeani delagardellemenlo parkjeani delagardellenew yorkassociates domain owner princetondomain partners viii lp owner princetonbrian h dovey owner princetondp viii associates lp owner princetonmichael w dunnechief medical officer morristownmichael w dunnechief medical officer chicagomichael w dunnechief medical officer chicagopaul r edickchief executive officer morristownpaul r edickchief executive officer chicagopaul r edickchief executive officer chicagosteve elmsnew yorksteve elmsnew yorkcorey n fishmancoo  cfo morristowncorey n fishmancfo  coo chicagocorey n fishmancfocoo chicagopaul a friedmandirector chicagopaul a friedmandirector chicagolisa m gilesdirector chicagolisa m gileschicagolisa m gilesdirector chicagodov a md goldsteindirector new yorkbrian k halak owner princetonjames healydirector menlo parkjames healymenlo parkgeorge f horner iiidirector morristownronald huntnew yorkronald huntdirector new yorkronald huntnew yorkkim p kamdarprincetonmilan kovacevicmorristownjeremy david lackmorristownvijay k lathimenlo parkvijay k lathimenlo parkvijay k lathinew yorknew leaf venture associates ii lpnew yorknew leaf venture associates ii lpnew yorknew leaf venture associates ii lpnew yorknew leaf ventures ii lpnew yorknew leaf ventures ii lp owner new yorkjames niedelnew yorkjames niedelnew yorkkevin c oboyledirector chicagokevin c oboyledirector chicagokevin c oboylemorristownbenjamin manlaui pemorristownbenjamin manlavi pechicagomichael powellmenlo parkdennis j purcellnew yorkdennis j purcellnew yorkliam ratcliffenew yorkandrew n schiffnew yorkandrew n schiffnew yorkkathleen k schoemaker owner princetonjohn patrick shannon jrmorristownjohn patrick shannon jrchief commercial officer chicagojohn patrick shannon jrchief commercial officer chicagosofinnova management vii llcmenlo parksofinnova venture partners vii l pmenlo parkgeorge harrison talbotmorristownjesse i treu owner princetonronald irving trustmorristownronald irving trustchicagonicole vitullodirector princetonwendy l yarnochicagowendy l yarnodirector chicago potentially same personnamecitycountrynew leaf venture management ii llcnew yorknynew leaf venture management ii llcnew yorknynew leaf venture management ii llcnew yorknynew leaf venture management ii llcnew yorkny new leaf venture management ii llc  profile of ceo director businessman bizpediaxyz  we monitor changes in companies new leaf venture management ii llc  profile of ceo director businessman free email watchdog get free email notifications about news for new leaf venture management ii llc the service is free and you can unsubscribe at any time new leaf venture management ii llc  check out list of companies related to new leaf venture management ii llc find out people related to new leaf venture management ii llc  coworkers  colleagues  companions address co new leaf ventures times square tower  times sq ste  new york  ny companies related to new leaf venture management ii llc ciknamestatecikirsstockworld heart corpdelawarewhrticagen incdelawareicgnmei pharma incdelawaremeipoxford immunotec global plcoxfdchimerix incdelawarecmrxversartis incvsardurata therapeutics incdelawaredrtx people related to new leaf venture management ii llc company world heart corpnamecitycountryabiomed incdanversmaabiomed incdanversmaakkaraju srinivasmenlo parkcaanders hovesalt lake cityutaustin marxesalt lake cityutbecker steven rdallastxbrown morgan roaklandcabrown morgan rsalt lake cityutbrown morgan rsalt lake cityutcamber capital management llcbostonmacamber capital management llcbostonmacarlson john fst paul mnchambon philippenew yorknychambon philippenew yorknychambon philippe onew yorknycompton gayla jpalo altocacompton kevin rpalo altocadelagardelle jeanimenlo parkcadelagardelle jeanisalt lake cityutdelagardelle jeanimenlo parkcadelagardelle jeanisalt lake cityutdelagardelle jeanisalt lake cityutestes michael sumneroaklandcaestes michael sumnersalt lake cityutestes michael sumnersalt lake cityuteugene jonessalt lake cityutgarriock william ctoronto on canadagarriock william coaklandcagarriock william csalt lake cityutgarriock william csalt lake cityutgarriock william csalt lake cityutgoertz gary woaklandcagoertz gary wsalt lake cityutgoudie d markstittsville on canadahove anders dnew yorknyhove anders dpalo altocahunt ronaldnew yorknyhunt ronaldnew yorknyjal jassawallasalt lake cityutjansen piet nl amsterdam netherlandsjansen pietoaklandcajassawalla jal sorindacajassawalla jal soaklandcajassawalla jal soaklandcajassawalla jal ssalt lake cityutjassawalla jal ssalt lake cityutjeani delagardellesalt lake cityutjohn martinsalt lake cityutjones eugene bsalt lake cityutjones eugene bsalt lake cityutjuelis a richardoaklandcajuelis a richardoaklandcakhanwilkar pratapsalt lake cityutkhanwilkar pratapoaklandcakhanwilkar pratapoaklandcakhanwilkar pratapsalt lake cityutlaporte kathleenmenlo parkcalathi vijay kmenlo parkcalathi vijay kmenlo parkcamajteles robert jpiedmontcamajteles robert joaklandcamarinchak johnwalnut creekcamartin john alexanderoaklandcamartin john alexandersalt lake cityutmartin john alexandersalt lake cityutmarxe austin wnew yorknymarxe austin wsalt lake cityutmarxe austin w  greenhouse david mnew yorknymarxe austin w  greenhouse david mnew yorknymaverick venture management llcpalo altocamedquest products incsalt lake cityutmedquest products incsalt lake cityutmichael estessalt lake cityutmichael estes phdsalt lake cityutmiller phillipberkeleycamiller phillipoaklandcamiller phillipoaklandcaminogue michael rsalt lake cityutmorgan brownsalt lake cityutnew leaf venture associates ii lpnew yorknynew leaf venture associates ii lpnew yorknynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorknyniedel jamesnew yorknyniedel jamesnew yorknypellone davidoaklandcaphillip millersalt lake cityutpratap khanwilkarsalt lake cityutross c iancollingwood on canadaross c ianoaklandcaroth michaelst franciswismith g stacydallastxsmith g stacydallastxsmith g stacydallastxsrb management lpdallastxstark brian jayst franciswistark brian jayst franciswivajda john joaklandcavajda john joaklandcavef management v llcpalo altocavef management v llcpalo altocavenrock associates v lppalo altocavenrock associates v lppalo altocavenrock entrepreneurs fund v lppalo altocavenrock entrepreneurs fund v lppalo altocavenrock management v llcpalo altocavenrock management v llcpalo altocavenrock partners management v llcpalo altocavenrock partners management v llcpalo altocavenrock partners v l ppalo altocavenrock partners v l ppalo altocawalker patrick pdallastxwalker patrick pdallastxwalker patrick pdallastxwalker reid sdallastxwalker reid sdallastxwalker reid sdallastxwalker reid sdallastxwalker smith capital l pdallastxwalker smith capital qp l pdallastxwalker smith international fund ltddallastxwalker smith international ltddallastxwalker smith international ltddallastxwalker smith international ltddallastxwilliam garriocksalt lake cityutwoodard johnsalt lake cityutws capital llcdallastxws capital llcdallastxws capital management lpdallastxws capital management lpdallastxws capital management lpdallastxws opportunity fund international ltddallastxws opportunity fund international ltddallastxws opportunity fund international ltddallastxws opportunity fund international ltddallastxws opportunity fund l pdallastxws opportunity fund qp l pdallastxws ventures management l pdallastxws ventures management l pdallastxws ventures management l pdallastxwsv management l l cdallastxwsv management l l cdallastxwsv management l l cdallastxpeople related to new leaf venture management ii llc company icagen incnamecitycountryabbott laboratoriesabbott parkilakkaraju srinivasmenlo parkcaalimentaria international inclausanneswitzerlandalta biopharma management llcsan franciscocaalta biopharma partners lpsan franciscocaalta chase biopharma management llcsan franciscocaalta embarcadero biopharma partners llcsan franciscocaalta partnerssan franciscocabecker steven rdallastxbiotechnology value fund ii lpchicagoilbiotechnology value fund ii lpchicagoilbiotechnology value fund l pchicagoilbiotechnology value fund l pchicagoilbvf incilchicagoilbvf investments llcchicagoilbvf partners l pilchicagoilbvf partners l pilchicagoilcape holdingparisfrancecdib bioventures inctaipeitaiwan province of chinachambon philippe onew yorknychatain jacquesparisfrancechina development industrial bank inctaipeitaiwan province of chinacredit agricole s aparisfrancedelagardelle jeanimenlo parkcadeleage jeansan franciscocaeclipse acquisition corpnew yorknyeuropean medical venturesparisfranceevnin anthony bnew yorknyevnin anthony bnew yorknyfinove ltdst helierunited kingdomfonds de solidarite des travailleurs du quebecmontrealagillings dennis b ph ddurhamncgillings dennis b ph ddurhamncgillings dennis b ph ddurhamncgillings dennis b ph ddurhamncgillings dennis b ph ddurhamncgiordano douglas enew yorknygray edward pdurhamncgruener garrettsan franciscocagutrafin ltdveltheimswitzerlandhbm bioventures cayman ltdgrand caymancayman islandshetherington seth vdurhamnchetherington seth vdurhamnchoegh invest asoslonorwayhull heywarddurhamnchunt ronaldnew yorknyicagen chase partners alta bio llcsan franciscocaj p morgan partners sbic llcnew yorknyjakobs robert jamesdurhamncjanney danielsan franciscocajp morgan partners bhca lpnew yorknyjpmp capital corpnew yorknyjpmp master fund manager l pnew yorknykatz richard ddurhamnclamotte andredurhamnclamotte andredurhamnclampert mark nchicagoillathi vijay kmenlo parkcaleighton h jeffersondurhamnclilly eli  coindianapolisinmarduel alixsan franciscocamckernan ruthnew yorknymedical science ii coinvestment lpwalthammamedical science partners ii l pwalthammamedical science partners l pwalthammamerlin biomed private equity advisors llcnew yorknymilton private foundationzugswitzerlandmorrison richard gwilmingtonncmorrison richard gdurhamncneomed investments ltdhamiltonbermudanew leaf venture associates ii lpnew yorknynew leaf ventures ii lpnew yorknyniedel jamesnew yorknynohra guy psan franciscocaolukotun adeoye ydurhamncolukotun adeoye ydurhamncpfizer incnew yorknypharma services holding incpharma services holding incdurhamncpharma services intermediate holding corppharma services intermediate holding corpdurhamncqfinance incdurhamncqfinance incdurhamncquintiles transnational corpdurhamncquintiles transnational corpdurhamncroche william gnew yorknyround enterprises ltdst peter portunited kingdomsanders charles adurhamncselectra investment  management ii inclondonunited kingdomsemon dominiquenew yorknysimonetti martin adurhamncsimonetti martin adurhamncsmith g stacydallastxsmith g stacydallastxsmith g stacydallastxsrb management lpdallastxsupran bryannew yorknyvenrock associatesnew yorknyvenrock associates ii lpnew yorknyviking medical ventures ltdst helierunited kingdomwagoner kaydurhamncwagoner kaydurhamncwagoner kaydurhamncwalker patrick pdallastxwalker patrick pdallastxwalker reid sdallastxwalker reid sdallastxwalker smith capital l pdallastxwalker smith capital qp l pdallastxwalker smith international fund ltddallastxws capital llcdallastxws capital llcdallastxws capital llcdallastxws capital management lpdallastxws capital management lpdallastxws opportunity fund international ltddallastxws opportunity fund l pdallastxws opportunity fund qp l pdallastxws ventures management l pdallastxws ventures management l pdallastxws ventures management l pdallastxwsv management l l cdallastxwsv management l l cdallastxwsv management l l cdallastxyasuda enterprise development co ltdtokyojapanyasuda enterprise development ii lptokyojapanpeople related to new leaf venture management ii llc company mei pharma incnamecitycountryakkaraju srinivasmenlo parkcaaustin josiah tdallastxbaltic charles v iiisan diegocabaltic charles v iiisan diegocabaltic charles v iiisan diegocabaltic charles v iiisan diegocabaltic charles v iiisan diegocabaltic charles v iiisan diegocabreckenridge stephennorth ryde nsw australiabryan williamssan diegocacann leah rushsan diegocacann leah rushsan diegocacann leah rushsan diegocacann leah rushsan diegocachambon philippesunnyvalecachambon philippe onew yorknychristine whitesan diegocaclemens kevancharlottencclemens kevansan diegocadaniel goldsan diegocade kretser david morritznorth ryde nsw australiadelagardelle jeanimenlo parkcadelagardelle jeanimenlo parkcadrazba brian girvinecael coronado holdings llcdallastxglover nicholassan diegocaglover nicholassan diegocaglover nicholassan diegocagold daniel p phdsan diego cagold daniel p phdnew south walesaustraliagold daniel p phdsan diegocagold daniel p phdsan diegocagold daniel p phdsan diegocahunt ronaldnew yorknyhunt ronaldnew yorknyjohnston philip anorth ryde nsw australiajohnston philip anorth ryde nswaustraliakelly graham enorth ryde nsw australialathi vijay kmenlo parkcalathi vijay kmenlo parkcaleah cannsan diegocamass robert dsan diegocamass robert dsan diegocamass robert dsan diegocanaughton christophernorth ryde nsw australianaughton christophernorth ryde nswaustralianestel paul jnorth ryde nsw australianew leaf venture associates ii lpnew yorknynew leaf venture associates ii lpnew yorknynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorknyniedel jamesnew yorknynovogen ltdsydneyaustralianovogen ltdnorth ryde nswaustralianovogen ltdnorth ryde nswaustralianovogen ltdnorth ryde nswaustraliaratcliffe liamnew yorknyratcliffe liamnew yorknyreynolds thomas cbothellwareynolds thomas csan diegocareynolds thomas csan diegocarueckert william dodgehendersonnvrueckert william dodgenorth ryde nswaustraliarueckert william dodgesan diegocarueckert william dodgesan diegocarueckert william dodgesan diegocarueckert william dodgesan diegocaseaton david rnorth ryde nsw australiaseaton david rnorth ryde nswaustraliathomas zechsan diegocaurso david msan diegocaurso david msan diegocavivo ventures fund v lppalo altocavivo ventures fund v lppalo altocavivo ventures fund vii lppalo altocavivo ventures fund vii lppalo altocavivo ventures v affiliates fund lppalo altocavivo ventures v affiliates fund lppalo altocavivo ventures v llcpalo altocavivo ventures v llcpalo altocavivo ventures vii affiliates fund lppalo altocavivo ventures vii affiliates fund lppalo altocavivo ventures vii affiliates fund lppalo altocavivo ventures vii llcpalo altocavivo ventures vii llcpalo altocawhite christine annasan diegocawhite christine annasan diegocawhite christine annasan diegocawhite christine annasan diegocawilliam rueckertsan diegocawilliams bryannorth ryde nswaustraliawilliams bryannorth ryde nswaustraliawilliams bryansan diegocawilliams bryansan diegocazech thomas mnew south walesaustraliazech thomas msan diegocazech thomas msan diegocazech thomas msan diegocazech thomas msan diegocapeople related to new leaf venture management ii llc company oxford immunotec global plcnamecitycountryaltieri richard mabingdonunited kingdomaltieri richard mabingdon oxfordshireunited kingdomandrews ronald asburysan juan capistranocabalthrop patrick jchicagoilchambon philippe onew yorknychambon philippe onew yorknyclarus lifesciences i lpcambridgemaclarus lifesciences i lpcambridgemaclarus ventures i llccambridgemaclarus ventures i llccambridgemaclarus ventures i management lpcambridgemaclarus ventures i management lpcambridgemadelagardelle jeanimenlo parkcaedwardson peterabingdonunited kingdomedwardson peterabingdon oxfordshireunited kingdomgalakatos nicholasbostonmagalakatos nicholascambridgemahenner dennissouth san franciscocahenner denniscambridgemahunt ronaldnew yorknyhunt ronaldnew yorknykeiley elizabeth mabingdon oxfordshireunited kingdomkeiley elizabeth mabingdon oxfordshireunited kingdomlathi vijay kmenlo parkcaliptak robertbostonmaliptak robertcambridgemanew leaf venture associates ii lpnew yorknynew leaf venture associates ii lpnew yorknynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorknyniedel jamesnew yorknyniedel jamesnew yorknypitchford nigel aabingdonunited kingdomrandall patricianewtonmarandall patriciaabingdonunited kingdomrandall patriciaabingdon oxfordshireunited kingdomratcliffe liamnew yorknyrosenman hermsan diegocarosenman hermabingdon oxfordshireunited kingdomrosenman hermabingdonunited kingdomsandberg richard adanburyctsandberg richard aabingdonunited kingdomsandberg richard aabingdon oxfordshireunited kingdomschroeder jeff rabingdonunited kingdomschroeder jeff rabingdon oxfordshireunited kingdomsimon nicholascambridgemasimon nicholascambridgemaspotts stephen lcarlsbadcaspotts stephen labingdonunited kingdomspotts stephen labingdon oxfordshireunited kingdomsteinmetz michaelcambridgematobin james rtobin james rabingdon oxfordshireunited kingdomwalton andrew scottburlingtonncwenstrup richardsalt lake cityutwheeler kurtbostonmawheeler kurtcambridgemawrightonsmith peterabingdonunited kingdomwrightonsmith peterabingdon oxfordshireunited kingdompeople related to new leaf venture management ii llc company chimerix incnamecitycountryam pappas life science ventures iii lpresearch triangle parkncam pappas life science ventures iii lpresearch triangle parkncam pappas life science ventures iv lpresearch triangle parkncam pappas life science ventures iv lpresearch triangle parkncalta biopharma partners iii gmbh  co beteiligungs kgsan franciscocaalta biopharma partners iii gmbh  co beteiligungs kgsan franciscocaalta biopharma partners iii lpsan franciscocaalta embarcadero biopharma partners iii llcsan franciscocaalta embarcadero biopharma partners iii llcsan franciscocaarthur pappasdurhamncberrey m michelleprincetonnjberrey m michelledurhamncberrey m michelledurhamnccanaan partners vii llcwestportctcanaan partners vii llcwestportctcanaan partners vii llcwestportctcanaan vii l pwestportctcanaan vii l pwestportctchambon philippe onew yorknychampsi farahsan franciscocachampsi farahdurhamncdaly james mwilmingtondedaly james mdurhamncdelagardelle jeanimenlo parkcadelagardelle jeanisan mateocademski martha jsan diegocademski martha jdurhamncdemski martha jdurhamncdrake rodman ldurhamncdrake rodman ldurhamncedward penhoet phdsan franciscocafarah champsisan franciscocageorge painter phddurhamncgeorge painter phddurhamncgilliss catherinedurhamncgraham crooke mbbspalo altocagwendolyn painter md mphdurhamnchunt ronaldnew yorknyhutton wende sdurhamnchutton wende sdurhamnchutton wende sdurhamncjames niedelnew yorknykenneth mochdurhamnckenneth mochdurhamnclathi vijay kmenlo parkcalathi vijay ksan mateocaleonard john mnorth chicagoilleonard john mdurhamncmachado clarence patricksan franciscocamachado clarence patrickdurhamncmario ernestmario ernestdurhamncmario ernestdurhamncmartha demskidurhamncmartha demskidurhamncmerrick almond phddurhamncmoch kenneth idurhamncmoch kenneth idurhamncmoch kenneth idurhamncnew leaf venture associates ii lpnew yorknynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorknynichols garrettdurhamncniedel jamesnew yorknyniedel jamesdurhamncniedel jamesnew yorknyniedel jamesdurhamncniedel jamesdurhamncpappas arthur mdurhamncpappas arthur mdurhamncpappas arthur mdurhamncpv iii ceo fund lpresearch triangle parkncpv iii ceo fund lpresearch triangle parkncpv iv ceo fund lpresearch triangle parkncpv iv ceo fund lpresearch triangle parkncratcliffe liamnew yorknyrenaud ronald c jrnew yorknyrenaud ronald c jrdurhamncricciardi lisamarlboroughmaricciardi lisadurhamncrichardson linda mdurhamncrogers michael dprincetonnjrogers michael ddurhamncrogers michael ddurhamncrosemary omahony phddurhamncsanderling v beteiligungs gmbh  co kgsan mateocasanderling v beteiligungs gmbh  co kgsan mateocasanderling v beteiligungs gmbh  co kgsan mateocasanderling v biomedical co investment fund lpsan mateocasanderling v biomedical co investment fund lpsan mateocasanderling v biomedical co investment fund lpsan mateocasanderling v biomedical co investment fund lpsan mateocasanderling v biomedical lpsan mateocasanderling v biomedical lpsanderling v biomedical lpsan mateocasanderling v ltd partnershipsan mateocasanderling v ltd partnershipsan mateocasanderling v strategic exit fund lpsan mateocasanderling v strategic exit fund lpsan mateocasanderling v strategic exit fund lpsan mateocasanderling venture partners v co investment fund lpsan mateocasanderling venture partners v co investment fund lpsan mateocasanderling venture partners v lpsan mateocasanderling venture partners v lpsan mateocasanderling venture partners vi co investment fund lpsan mateocasanderling venture partners vi co investment fund lpsan mateocasanderling ventures management vsan mateocasanderling ventures management vsan mateocasanderling ventures management visan mateocasanderling ventures management visan mateocasanderling vi beteiligungs gmbh  co kgsan mateocasanderling vi beteiligungs gmbh  co kgsan mateocasanderling vi limited partnershipsan mateocasanderling vi limited partnershipsan mateocaseth rudnick mdwestportctseth rudnick mdwestportcttimothy wollaegersan mateocatimothy wollaegersan mateocatrost timothy wdurhamnctrost timothy wdurhamncwollaeger timothydurhamncwollaeger timothydurhamncpeople related to new leaf venture management ii llc company versartis incnamecitycountryadvent life sciences fund i lplondonunited kingdomadvent life sciences llplondonunited kingdomaisling capital iii lpnew yorknyaisling capital partners iii llcnew yorknyaisling capital partners iii lpnew yorknyakkaraju srinivasakkaraju srinivasmenlo parkcaanthony sunredwood citycaanthony sunredwood citycabrumm joshua tpleasantoncabrumm joshua tredwood citycabrumm joshua tmenlo parkcachambon philippe onew yorknychambon philippe onew yorknycleland jeffrey lredwood citycacleland jeffrey lmenlo parkcade rubertis francescolondonunited kingdomdelagardelle jeanimenlo parkcadelagardelle jeanisan mateocadobmeier ericbothellwadybbs michaelnew yorknyedelman josephedmon jenningsredwood citycaedmon jenningsredwood citycaelms stevenew yorknyfrancesco de rubertisredwood citycafrancesco de rubertisredwood citycagreer r scottgreer r scottmenlo parkcahealy jamesmenlo parkcahislop colinhaywardcahunt ronaldnew yorknyhunt ronaldnew yorknyindex ventures iv jersey lpst helieryindex ventures iv jersey lpst helieryindex ventures iv jersey lpst helieryindex ventures iv jersey lpst helieryindex ventures iv parallel entrepreneur fund jersey lpst helieryindex ventures iv parallel entrepreneur fund jersey lpst helieryindex ventures iv parallel entrepreneur fund jersey lpst helieryindex ventures iv parallel entrepreneur fund jersey lpst helieryjay shepardredwood citycajeffrey clelandmountain viewcajeffrey clelandredwood citycajeffrey clelandredwood citycajennings edmon rsouth san franciscocajennings edmon rredwood citycajoshua brummredwood citycakevin johnsonredwood citycakevin johnsonmountain viewcalathi vijay kmenlo parkcalathi vijay ksan mateocamalik shahzadgaithersburgmdmalik shahzadlondonunited kingdommehra anandmenlo parkcamichael dybbsredwood citycamichael dybbsredwood citycanew leaf venture associates ii lpnew yorknynew leaf venture associates ii lpnew yorknynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorknyniedel jamesnew yorknyniedel jamesnew yorknypaul westbergredwood citycaperceptive advisors llcwashingtondcperceptive life sciences master fund ltdwashingtondcpowell michaelmenlo parkcapurcell dennis jnew yorknyratcliffe liamnew yorknyratcliffe liamnew yorknyschiff andrew nnew yorknyshahzad malikmountain viewcashahzad malikredwood citycashahzad malikredwood citycashepard jaycupertinocashepard jayredwood citycasofinnova management viii llcmenlo parkcasofinnova venture partners viii lpmenlo parkcasrinivas akkarajumountain viewcasrinivas akkarajuredwood citycasrinivas akkarajuredwood citycastout jay smenlo parkcasun anthony ynew yorknysun anthony ynew yorknyvarian johnfremontcavarian johnredwood citycavolker schellenbergerredwood citycaward shanemenlo parkcawestberg paulredwood citycawestberg paulmenlo parkcawillem stemmermountain viewcawillem stemmerredwood citycawoody tracy mcoralvilleiayucca jersey slpst helieryyucca jersey slpst helieryyucca jersey slpst helierypeople related to new leaf venture management ii llc company durata therapeutics incnamecitycountryahrens brenton karlwestportctahrens brenton karlwestportctaisling capital iii lpnew yorknyaisling capital iii lpnew yorknyaisling capital partners iii llcnew yorknyaisling capital partners iii llcnew yorknyaisling capital partners iii lpnew yorknyaisling capital partners iii lpnew yorknyakkaraju srinivasmenlo parkcaakkaraju srinivasmenlo parkcaallen susan robertamorristownnjbirchler angela gurskimorristownnjblair james cprincetonnjbuatois ericmenlo parkcacanaan management incwestportctcanaan management incwestportctcanaan partners viii llcwestportctcanaan partners viii llcwestportctcanaan viii lpwestportctcanaan viii lpwestportctcarroll j martinchicagoilcarroll j martinchicagoilchambon philippe onew yorknychambon philippe onew yorknychambon philippe onew yorknyde schutter richard uchicagoilde schutter richard umorristownnjde schutter richard uchicagoilde schutter richard uchicagoildelagardelle jeanimenlo parkcadelagardelle jeanimenlo parkcadelagardelle jeaninew yorknydomain associatesprincetonnjdomain partners viii lpprincetonnjdovey brian hprincetonnjdp viii associates lpprincetonnjdunne michael wmorristownnjdunne michael wchicagoildunne michael wchicagoiledick paul rmorristownnjedick paul rchicagoiledick paul rchicagoilelms stevenew yorknyelms stevenew yorknyfishman corey nmorristownnjfishman corey nchicagoilfishman corey nchicagoilfriedman paul achicagoilfriedman paul achicagoilgiles lisa mchicagoilgiles lisa mchicagoilgiles lisa mchicagoilgoldstein dov a mdnew yorknyhalak brian kprincetonnjhealy jamesmenlo parkcahealy jamesmenlo parkcahorner george f iiimorristownnjhunt ronaldnew yorknyhunt ronaldnew yorknyhunt ronaldnew yorknykamdar kim pprincetonnjkovacevic milanmorristownnjlack jeremy davidmorristownnjlathi vijay kmenlo parkcalathi vijay kmenlo parkcalathi vijay knew yorknynew leaf venture associates ii lpnew yorknynew leaf venture associates ii lpnew yorknynew leaf venture associates ii lpnew yorknynew leaf ventures ii lpnew yorknynew leaf ventures ii lpnew yorknyniedel jamesnew yorknyniedel jamesnew yorknyoboyle kevin cchicagoiloboyle kevin cchicagoiloboyle kevin cmorristownnjpe benjamin manlauimorristownnjpe benjamin manlavichicagoilpowell michaelmenlo parkcapurcell dennis jnew yorknypurcell dennis jnew yorknyratcliffe liamnew yorknyschiff andrew nnew yorknyschiff andrew nnew yorknyschoemaker kathleen kprincetonnjshannon john patrick jrmorristownnjshannon john patrick jrchicagoilshannon john patrick jrchicagoilsofinnova management vii llcmenlo parkcasofinnova venture partners vii l pmenlo parkcatalbot george harrisonmorristownnjtreu jesse iprincetonnjtrust ronald irvingmorristownnjtrust ronald irvingchicagoilvitullo nicoleprincetonnjyarno wendy lchicagoilyarno wendy lchicagoil potentially same personnamecitycountrynew leaf venture management ii llcnew yorknynew leaf venture management ii llcnew yorknynew leaf venture management ii llcnew yorknynew leaf venture management ii llcnew yorkny new leaf venture management ii llc top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active new leaf venture management ii llc • new york ny how do i update this listing new leaf venture management ii is based out of new york summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from new leaf venture management ii llc enter your email address below and choose submit your email cancel contact info new leaf venture management ii llc times square tower new york ny     business phone   recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free new leaf venture partners  financial services firm new york new york  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesnew leaf venture partners new leaf venture partners overviewarticlesholdingsassetsservicesadvisorsleadershipfees share new leaf venture partners overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description new leaf venture partners is a ria based in new york ny with b in aum information type ria head quarters new york ny  of employees  total assets  website location new york ny   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on april   b total assets under management na total assets under advisement  accounts m estimated average account balance services firm services there is no services data available to display at this time firm client types advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets new leaf growth associates i lp   new leaf venture associates ii lp   new leaf venture associates iii lp   new leaf venture management i lp   new leaf venture management i llc   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership craig lawrence slutzkin chief financial officerchief compliance officer july  less than  jeani camarano delagardelle managing director july  less than  ronald martin hunt managing director july  less than  vijay kiran lathi managing director july  less than  liam thomas ratcliffe managing director june  less than  source sec fees types of compensation arrangements percentage of assets performancebased fees company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations brightscope  advisor pages  find a financial advisor or advisory firm getsearchtypedisplaynamesearchtype advisor funds firms k plans general search advisors advisory firms financial qa k plans funds search home    brightscope advisor pages    find a financial advisory firm advisor search firm search advisors by city find a financial advisory firm search firm name active firms only city state alabama alaska american samoa arizona arkansas california colorado connecticut delaware district of columbia florida georgia guam hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota northern marinara islands ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming firm service areas financial planning estate planning comprehensive financial planning retirement planning college planning charitable planning other financial planning tax planning insurance life insurance health insurance longterm care insurance annuities property  casualty insurance business insurance other insurance pension consulting k b  defined benefit other pension consulting portfolio management individuals andor small businesses investment companies businesses or institutional clients other portfolio management accounting  tax tax advice other tax legal legal planning legal advice other legal other publication of periodicals or newsletters security ratings or pricing services market timing services selection of other advisors educational seminarsworkshops see all service areas find filters financialplanningfindfirm compensation arrangements no preference fixed fees  hourly charges  performancebased fees  none  fee only  assets under mgmt no preference   k  m  m  m  m  m  m  b  b  avg account balance no preference   k  k  k  k  m  m  m  m  m  financial advisory firm search results  results merrill lynch pierce fenner  smith incorporated ny ny  advisors  aum  b wells fargo advisors llc st louis mo  advisors  aum  b jp morgan securities llc manhattan ny  advisors  aum  b morgan stanley smith barney llc harrison ny  advisors  aum  b lpl financial llc boston ma  advisors  aum  b edward d jones  co lp des peres mo  advisors  aum  b ameriprise financial services inc minneapolis mn  advisors  aum  b ubs financial services inc weehawken nj  advisors  aum  b northwestern mutual investment servicesllc milwaukee wi  advisors charles schwab  co inc south beach ca  advisors mml investors services llc pine point ma  advisors  aum  b goldman sachs  co ny ny  advisors  aum  b strategic advisers inc boston ma  advisors  aum  b citigroup global markets inc new york ny  advisors  aum  b raymond james  associates inc st petersburg fl  advisors  aum  b      company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations new leaf venture partners  financial services firm new york new york  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesnew leaf venture partners new leaf venture partners overviewarticlesholdingsassetsservicesadvisorsleadershipfees share new leaf venture partners overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description new leaf venture partners is a ria based in new york ny with b in aum information type ria head quarters new york ny  of employees  total assets  website location new york ny   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on april   b total assets under management na total assets under advisement  accounts m estimated average account balance services firm services there is no services data available to display at this time firm client types advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets new leaf growth associates i lp   new leaf venture associates ii lp   new leaf venture associates iii lp   new leaf venture management i lp   new leaf venture management i llc   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership craig lawrence slutzkin chief financial officerchief compliance officer july  less than  jeani camarano delagardelle managing director july  less than  ronald martin hunt managing director july  less than  vijay kiran lathi managing director july  less than  liam thomas ratcliffe managing director june  less than  source sec fees types of compensation arrangements percentage of assets performancebased fees company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations approach  nlvpartners select page the healthcare industry is ripe for disruption and we are partnering with the disruptors biopharmaceuticals information convergence medical devices life science tools we’re passionate about using technology to create efficiencies and improve outcomes in the healthcare industry and we’re partnering with teams who share our passion for innovation that provokes a new way of thinking about treatments devices and cures   nlvp has nurtured and built great companies with a singular goal to revolutionize healthcare we invest across the entire healthcare technology sector from public and private biopharmaceutical companies to early and late stage healthcare information technology companies to commercial medical device companies   with an exclusive focus on four sectors we are highly selective in choosing our partners when evaluating potential investments we look for capable teams solving real problems in unique ways here are some of the criteria we consider biopharmaceuticals nlvp invests in this sector from company creation through the initial public offering ipo and beyond we work with experienced management teams that have developed novel product programs and platforms exemplified by several key characteristics – including large unmet medical needs strong science well differentiated technologies and highquality preclinical and clinical development programs we believe that the best financial returns come from a focus on rigorous science and thorough data analysis so our approach is largely science and datadriven we currently invest in this sector through two vehicles nlviii – through our venture fund we seek to fund teams as early as the company creation stage through ipos nlv growthi – with our inaugural growth fund we invest in crossover rounds ipos public financings as well as open market purchases information convergence nlvp has more than  cumulative years of investment and operational experience in the information convergence sector we’ve built companies from small startup teams to businesses with revenues exceeding  million and each new company that joins our portfolio gains the same access to our shared knowledge as healthcare specialists attuned to the latest developments across the field we help our teams shape strategy by applying our market understanding and engaging them with an active advisory network that includes leaders from across the entire healthcare ecosystem – from cios of leading hospital systems and executives at major healthcare organizations to a broad network of experienced serial entrepreneurs who’ve built successful information convergence companies our history of building companies in healthcare information technology tools and diagnostics uniquely positions nlvp to identify and support promising companies in this sector medical devices the team at nlvp has decades of experience working with leading medical device companies to address unmet medical and clinical needs including the treatment of acute medical problems and chronic diseases we leverage this experience and the extensive networks we’ve built to advance our portfolio and give them the advantage of access and deep expertise in a variety of related disciplines that impact their business we are actively involved in helping our portfolio succeed in bringing to market important medical devices with the power to reduce costs and improve efficiencies in the healthcare system life science tools nlvp works closely with our portfolio teams to deliver products that accelerate the discovery process uncover novel insights into the biology of disease and health and personalize diagnoses and treatment because we’ve spent many years building substantial businesses in this sector we can apply our deep experience to help the companies in our portfolio develop strategies and build teams that are capable of deepening their hold on existing markets and expanding further into new territory we also share insights from our team’s broader experience in adjacent health care segments to give our portfolio partners an advantage across the entire health care landscape once we decide to bring a new company into our portfolio we engage all of nlvp in helping the team thrive we combine our investment team’s collaborative approach and areas of expertise involvement network passion and experience to give each of our portfolio team partners a distinct competitive advantage to achieve success page not found  relationship science news home advertising board and executive moves energy health care hedge funds m  a private equity technology page not found oops looks like you followed a bad link click here to start over are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ team  qpid health team executive teamboard of directorsinvestorsadvisory board quality reporting stan reiss general partner matrix partners brandon hull managing general partner cardinal partners philippe chambon managing director new leaf venture partners carl berke partner partners innovation fund julia adlermilstein phd assistant professor university of michigan john e osborn jd mipp senior advisor hogan lovells david w bates md msc senior vice president and chief innovation officer brigham and women’s hospital alan ezekowitz mbchb dphil faap cofounder president and ceo of abide therapeutics robert r fanning jr former ceo of northeast health systembeverly hospital john d halamka md ms chief information officer of beth israel deaconess medical center robert m wachter md interim chairman of the department of medicine ucsf mike doyle fachepresident and chief executive officer michael zalis md cofounder and chief medical officer david burke chief financial officer janine powell vice president of customer service jim dowling vice president of sales afik gal md vice president of product innovation registry solutionsmike doyle president and ceomichael zalis md cofounder and chief medical officercarl berke partner partners innovation fund carl’s career has spanned over  years in the practice and management of innovation to bring new technologies from lab to market he has been an active private equity investor as a member of angel healthcare investors llc and is a founder of mass medical angels he has served on the boards of quosa kasalis combinent infobionic and the sudanese education fund carl holds an ab degree from cornell university and received his phd in organic chemistry from the university of california at berkeley he also holds an appointment as lecturer in the biomedical enterprise program in the harvardmit division of health sciences and technology carl currently represents the fund on the boards of annovation sebacia and qpid healthphilippe chambon managing director new leaf venture partners philippe chambon is a managing director and concentrates on information convergence and biopharmaceutical investments he joined the sprout group in  and became a general partner in  before becoming one of the founders of new leaf in  over his career he has invested broadly in healthcare technology companies across multiple sectors and stages of development philippe served as manager in the healthcare practice of the boston consulting group from  to  from  to  he was an executive with sandoz pharmaceutical where he led strategic product development portfolio management and premarketing activities in his capacity as executive director of new product management philippe did graduate research in molecular immunology at the pasteur institute and earned a md phd from the university of paris philippe also has an mba from columbia university in new yorkbrandon hull managing general partner cardinal partners brandon hull is a cofounder of cardinal partners a medical and life sciences venture capital partnership established in  his investment experience began in  and includes all facets of health care services medical products and devices but he has particular range and expertise in healthcare information technology and technologyenabledservices brandon spent seven years in health services operations previously and has served on the boards of numerous healthcare and medical technology companies spanning the landscape of the healthcare economy from insurers and managed care payers inpatient and outpatient providers and consumer health markets past and present board seats include athenahealth athn visicu phillips medical coderyte m fluidnet novalis trizetto awarepoint and qpid health brandon received his ba from wheaton college chicago and his mba from the wharton school at the university of pennsylvaniastan reissgeneral partner matrix partners stan reiss is passionate about bringing cutting edge technology to market since joining matrix over a decade ago he has invested primarily in companies developing technically sophisticated components systems and software including healthcare information technology  his investments include acacia communications fastback networks qpid health qualtre and xtalic stan received a bachelor’s degree in electrical engineering at cornell university two engineering masters’ degrees from mit focused on communications networking and an mba from the harvard business school where he was a baker scholar qpid technologycardinal partners since  cardinal partners has been one of the leading venture capital partnerships focused exclusively on healthcare investing cardinal specializes in early stage financing rounds usually as the lead investor in the initial financing round of a growth company cardinal’s investors include university endowments foundations pension funds banks and insurance companies cardinal currently manages funds totaling  millionmassachusetts general physicians organization the massachusetts general physicians organization mgpo is a multispecialty medical group dedicated to excellence and innovation in patient care teaching and researchmatrix partners matrix partners is a premier venture capital firm that has generated outstanding returns for more than three decades by focusing on earlystage investments and emphasizing longterm relationships with entrepreneurs the firm has delivered several of the industry’s top performing funds of all time matrix partners has offices in cambridge and waltham ma palo alto ca mumbai india and beijing and shanghai china matrix partners has invested in several gamechanging industryleading businesses such as apple computer aruba hubspot jboss netezza phonecom polyvore starent networks tivoli systems veritas zendesk and zongnew leaf venture partners new leaf venture partners is a leading healthcare technology venture firm  we invest broadly across healthcarerelated information technology companies as well as both public and private biopharmaceutical companies new leaf currently manages two funds new leaf ventures i lp and new leaf ventures ii lp nlvii as well as the healthcare technology portfolio of the sprout group one of the oldest us venture capital fund groups  new leaf’s current active fund nlvii has committed  million to companies in the healthcare it sector and  million to firms in the biopharmaceutical sector  for more information please visit httpwwwnlvpartnerscompartners innovation fund the partners innovation fund established in  was launched with a total commitment of  million from brigham and women’s hospital and massachusetts general hospital it addresses partners healthcare’s unmet need for funding of earlystage technology to drive improved medical care for patients qpid technologydavid w bates md msc chief of the division of general internal medicine and primary care at brigham and women’s hospital professor of medicine at harvard medical school and professor of health policy and management at the harvard school of public healthalan ezekowitz mbchb dphil faap cofounder president and ceo of abide therapeuticsjohn d halamka md ms a professor of medicine at harvard medical school and chief information officer of beth israel deaconess medical centerjulia adlermilstein phd an assistant professor at university of michigan whose research focuses on policy and management issues related to the use of it in healthcare deliveryjohn e osborn jd mipp a senior advisor with the international law firm hogan lovells executive in residence with the healthcare group of warburg pincus a regular contributor to forbescom and a faculty member at the university of washington seattlerobert m wachter md a professor of medicine at the university of california san francisco ucsf associate chairman of ucsf’s department of medicine and chief of ucsf’s faculty division of hospital medicine see a demo scroll to top new leaf venture partners llc company profile  bloomberg feedback new leaf venture partners llc private company company profile sector financials industry asset management subindustry private equity new leaf venture partners llc operates as a venture capital firm the company invests in biopharmaceutical information convergence medical devices and biological research companies new leaf venture partners serves customers in the states of new york and california corporate information address times square tower  times square suite  new york ny  united states phone  fax  web url wwwnlvpartnerscom from the web key executives ronald m hunt ron managing directorcofounder jeani delagardelle managing directorcofounder vijay lathi managing directorcofounder liam ratcliffe managing director james niedel jim venture partnercofounder jeffrey ives jeff venture partner isaac manke partnerpublic equity craig slutzkin cfocao dan becker principal eric kim vice president rebecca luse vice president show more show less sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data portfolio  nlvpartners select page with the success of our entrepreneurs our portfolio has  billiondollar companies  acquired companies and  companies taken public with more to come our companiesall companiesactivealumnibiopharmaceuticalsallactivealumniinformation convergenceallactivealumnimedical devicesmedical devicesallactivealumnilife science toolsallactivealumni nlv–iii aicure artificial intelligence platform that confirms medication adherence in clinical trials and highrisk patient populations new york ny nlv–iii arvinas platform for smallmolecule drugs that induce targeted degradation of diseasecausing intracellular proteins new haven ct nlviii aptinyx novel nmda modulator small molecule platform company for challenging neurological disorders evanston il nlv–iii  growth deciphera proprietary platform of novel kinase inhibitors for the treatment of cancer lead programs altiratinib targeting met and dcc targeting kit are clinical stage waltham ma nlv–iii  growth dimension therapeutics liverfocused gene therapy platform addressing genetic diseases with high need including hemophilia and orphan metabolic diseases cambridge ma nasdaq dmtx nlv–iii  growth edge therapeutics microparticle polymerbased therapies for subarachnoid hemorrhage and other acute lifethreatening neurologic conditions clinical stage berkeley heights nj nasdaq edge nlv  iii iterum therapeutics novel antibiotic drug development ireland  chicago il nlv–iii harpoon therapeutics next generation tcell engaging biologics targeting cancer and other diseases based on its proprietary tritac™ platform south san francisco ca nlv–iii kyruus enterprise solution to help health systems optimize their patient access referral management capacity utilization and care coordination efforts boston ma nlv–iii ny digital health accelerator a program run by the new york ehealth collaborative and the partnership fund of new york city for early and growthstage digital health companies new york ny nlv–iii rock health a fullservice seed fund and startup accelerator focused on building the next generation of technologies transforming healthcare san francisco ca nlv–iii  growth unum universal cellular immunotherapy for cancer coupling tumorspecific antibodies to geneticallymodified t cells clinical stage cambridge ma nlv–growth alder proprietary platform technologies for antibody selection and production lead program targets cgrp for migraine clinical stage bothell wa nasdaq aldr nlvgrowth crispr therapeutics gene editing platform using crisprcas technology to develop therapeutics that modify or correct a disease causing abnormality in a specific dna segment cambridge ma nasdaq crsp nlv–growth dermira differentiated therapies for dermatology including cimzia for psoriasis a topical anticholinergic for hyperhidrosis and a topical sebum inhibitor for acne clinical stage menlo park ca nasdaq derm nlv–growth dynavax therapies based on tolllike receptor tlr biology including vaccine adjuvants cancer immunotherapy and autoimmunity clinical stage berkeley ca nasdaq dvax nlv–growth marinus synthetic analog of the endogenous neurosteroid allopregnanolone for epilepsy and other neuropsychiatric disorders clinical stage radnor pa nasdaq mrns nlvgrowth true north therapeutics biotechnology company developing novel therapies that selectively inhibit the complement system to treat diseases in the hematologic kidney transplant and skin therapeutic areas south san francisco ca nlv–growth wave life sciences proprietary synthetic chemistry platform for stereopure nucleic acid therapeutics that target the underlying cause of rare genetic diseases boston ma nasdaq wve nlv–ii acadia pharmacuuticals innovative therapies for disorders of the central nervous system lead program is an ssia targeting hta receptors for psychosis clinical stage san diego ca nasdaq acad nlv–ii advanced cell diagnostics acquired by biotechne revenue stage research tools and diagnostics company with the leading technology for rna in situ detection hayward ca nlv–ii  growth afferent pharmaceuticals acquired by merck firstinclass selective px inhibitors providing a transformative approach to treating cough and other neurogenic conditions spunout of roche san mateo ca nlv–ii altura medical acquired by lombard medical developing medical devices for treatment of abdominal aortic aneurysms menlo park ca nlv–ii array biopharma targeted small molecule drugs for cancer boulder co nasdaq arry nlv–ii audax health solutions acquired by optum unitedhealth engagement platform for consumers to interact with payers washington dc nlv–ii awarepoint hospital based realtime location system rtls solutions to drive efficiency and care quality san diego ca nlv–ii calchan novel statedependent calcium channel modulators for chronic pain spunout of gskconvergence cambridge uk nlv–ii calithera biosciences firstinclass cancer drugs targeting tumor metabolism and immunooncology clinical stage south san francisco ca nasdaq cala nlv–ii cardiokinetix intracardiac device implant parachute which treats heart failure by improving overall cardiac function menlo park ca nlv–ii chimerix developer of new antiviral medicines for the treatment of lifethreatening diseases durham nc nasdaq cmrx nlv–ii convergence pharmaceuticals acquired by biogen novel analgesics based on state dependent ion channel pharmacology and medicinal chemistry platform cambridge uk nlv–ii durata therapeutics acquired by actavis developed dalbavancin an antibiotic active against grampositive bacteria spunout of pfizer now an approved drug chicago il nasdaq drtx nlvii epizyme epigenetic drug development for the treatment of cancer cambridge ma nlv–ii intercept pharmaceuticals novel therapeutics for liver diseases based on bile acid chemistry new york ny nasdaq icpt nlv–ii irhythm technologies cardiac arrhythmia diagnostic and monitoring platform san francisco ca nasdaq irtc nlv–ii karos pharmaceuticals therapeutic agents for the treatment of pulmonary arterial hypertension and other fibrosisdriven diseases targeting a novel mechanism of action new haven ct nlv–ii karus therapeutics novel smallmolecule drugs targeting pik and hdac to treat cancer and inflammation oxfordshire uk nlvii  growth karyopharm therapeutics novel firstinclass drugs directed against nuclear transport targets for cancer and other serious conditions clinical stage newton ma nasdaq kpti nlv–ii kit check automating hospital inventory management of pharmacy kits crash carts and anesthesia kits washington dc nlv–ii mei pharma smallmolecule drugs for cancer clinical stage san diego ca nasdaq meip nlv–ii neuronetics commercial stage device company with innovative technology for the noninvasive nonpharmacologic treatment of major depression malverne pa nlv–ii oxford immunotec commercializing novel diagnostics monitoring immune function for latent tuberculosis other infectious diseases and transplant marlborough ma nasdaq oxfd nlv–ii principia biopharma bestinclass medicines for immunology autoimmune diseases and oncology using their proprietary reversible covalent chemistry platform clinical stage south san francisco ca nlv–ii qpid health acquired by evicore healthcare business intelligence tool for hospitals and medical groups to extract data stored in ehrs and other clinical data repositories for clinical insights and quality reporting boston ma nlv–ii spiracur acquired by acelitykc commercial stage company with novel devices allowing portable nonpowered products for negative pressure chronic wound therapy sunnyvale ca nlv–ii synageva biopharma acquired by alexion therapies for rare diseases with high unmet medical need clinical stage lexington ma nasdaq geva nlv–ii tigertext secure mobile messaging platform that allows hipaa compliant real time communication and care coordination santa monica ca nlv–ii treato leading source of insights from millions of health consumers to turn billions of disparate online conversations into meaningful social intelligence about drugs and diseases yehud israel nlv–ii truveris software and analytics platform to drive transparency and lower costs across the prescription drug ecosystem new york ny nlv–ii versartis novel longacting recombinant human growth hormone using amunix’s xten technology clinical stage mountain view ca nasdaq vsar nlv–ii world heart acquired by heartware clinical stage company developing a left ventricular assist device for congestive heart failure oakland ca nasdaq whrt nlv–i access closure acquired by cardinal health commercial stage company developing medical devices for vascular closure mountain view ca nlv–i barrier therapeutics acquired by stiefel a glaxosmithkline company pharmaceuticals for dermatology princeton nj nasdaq btrx nlv–i biorelix biotech product platform company focused on discovery and development of novel targets in infectious disease new haven ct nlv–i cerexa acquired by forest laboratories antibiotics for serious lifethreatening infections alameda ca nlv–i concert pharmaceuticals inc deuterium based chemistry platform to improve the properties of existing drugs lexington ma nasdaq cnce nlv–i direct flow commercialclinical stage company focusing on development of novel percutaneous aortic valves santa rosa ca nlv–i illuminoss medical clinical stage device company developing innovative percutaneous solutions for fracture repair east providence ri nlv–i  growth intarcia therapeutics proprietary subcutaneous delivery platform lead program is exenatide a transformational once or twiceyearly treatment for type  diabetes clinical stage boston ma nlv–i interlace medical acquired by hologic commercial stage company focused on inoffice polypectomymyomectomy market newton ma nlv–i oriel therapeutics acquired by sandoz espiratory drug delivery and development company focusing on medicines for asthma and pulmonary disease clinical stage research triangle park nc nlv–i pearl therapeutics acquired by astrazeneca therapeutics for respiratory diseases spin out of technology from nektar redwood city ca nlv–i relypsa patiromer fos for hyperkalemia based on proprietary nonabsorbed polymeric technology spunout of amgenilypsa clinical stage santa clara ca nasdaq rlyp nlv–i reshape medical commercial stage device company focused on minimally invasive devices for the treatment of obesity san clemente ca nlv–i stromedix acquired by biogen novel therapies for fibrosis clinical stage spunout from biogen cambridge ma nlv–i tioga pharmaceuticals highly selective kappaopioid receptor agonist for pruritus associated with atopic dermatitis clinical stage san diego ca nlv–i transcept pharmaceuticals specialty pharmaceuticals that utilize buccal delivery technology lead program in insomnia pt richmond ca nasdaq tspt nlv–i vaxinnate vaccines for both pandemic and seasonal influenza as well as other infectious diseases based on proprietary tolllike receptor tlr technology platform clinical stage cranbury nj sprout adeza biomedical acquired by cytyc corp diagnostics for women’s health sunnyvale ca nasdaq adza sprout adolor acquired by cubist novel biopharmaceuticals to treat pain and to relieve the side effects of current pain medications exton pa nasdaq adlr sprout affymax biologic drug to treat anemia associated with chronic renal failure palo alto ca nasdaq affy sprout allos therapeutics acquired by spectrum small molecule drugs for cancer commercial stage westminster co nasdaq alth sprout aradigm pulmonary drug delivery devices hayward ca nasdaq ardm sprout aspire medical developer of medical devices for the treatment of obstructive sleep apnea osa sunnyvale ca sprout aspreva acquired by galenica therapies for autoimmune diseases victoria bc canada nasdaq aspv sprout atherogenics cardiovascular pharmaceuticals alpharetta ga nasdaq agix sprout auxilium pharmaceuticals acquired by endo specialty pharmaceuticals targeting connective tissue disorders and male health conditions commercial stage norristown pa nasdaq auxl sprout caredx commercializing noninvasive tests for transplant and autoimmunity brisbane ca nasdaq cdna sprout catalyst pharmaceutical partners drugs targeting rare neuromuscular and neurological diseases coral gables fl nasdaq cprx sprout cellgate oncologyfocused pharmaceuticals redwood city ca sprout cephalon acquired by teva approved drug for excessive daytime sleepiness frazer pa nasdaq ceph sprout charles river laboratories producer of drug discovery tools wilmington ma nasdaq crl sprout connetics acquired by stiefel laboratories drugs for rheumatology and dermatology palo alto ca nasdaq cnct sprout corixa acquired by glaxosmithkline immunotherapeutics seattle wa sprout ehealth first company to enable online purchasing of health insurance mountain view ca nasdaq ehth sprout endocardial solutions acquired by st jude medical arrhythmia mapping devices st paul mn sprout epicor acquired by st jude medical proprietary cardiac ablation platform to cure atrial fibrillation sunnyvale ca sprout epocrates acquired by athenahealth leading provider of drug and clinical decision support at the point of care san mateo ca nasdaq epoc sprout focus diagnostics acquired by quest diagnostics diagnostic and database services and products for infectious and immunological diseases herndon va sprout fougera pharmaceuticals acquired by novartis topical pharmaceutical products for dermatology melville ny sprout ilypsa acquired by amgen nonabsorbed drugs for renal disorders including a phosphate binder for hyperphosphatemia santa clara ca sprout intrabiotics pharmaceuticals antiinfective drugs sunnyvale ca nasdaq ibpi sprout intrinsic therapeutics late clinical stage company developing novel technology for annulus repair in spine surgery woburn ma sprout ista pharmaceuticals acquired by bausch  lomb specialty pharmaceuticals for ophthalmology commercial stage irvine ca nasdaq ista sprout kalypsys product platform for pathwaybased drug discovery san diego ca sprout labcyte merged from picoliter high throughput single picoliter volume fluid transfer for applications in screening genomics and mass spectrometry sunnyvale ca sprout lathian systems sales and marketing software for the pharmaceutical industry irvine ca sprout nuvelo therapeutics for cardiovascular disease cancer and other serious conditions merged from variagenics sunnyvale ca nasdaq nuvo sprout nxstage medical commercial stage device company offering treatments for endstage renal disease that enable home based dialysis therapy lawrence ma nasdaq nxtm sprout nycomed acquired by takeda specialty pharmaceuticals including branded generic and otc medications zurich switzerland sprout onyx pharmaceuticals acquired by amgen cancer therapeutics commercial stage emeryville ca nasdaq onxx sprout orquest acquired by depuy a johnson  johnson company orthopedic biologic devices mountain view ca sprout pathology partners acquired by caris deliverance of pathology diagnostic services and practice workflow solutions irving tx sprout pharsight acquired by tripos international software solutions for the optimization of clinical trials mountain view ca nasdaq phst sprout phase forward acquired by oracle leading electronic clinical trials data management solution waltham ca nasdaq pfwd sprout point biomedical imaging agents and drug delivery san carlos ca sprout prometheus laboratories acquired by nestlé health science specialty pharmaceuticals and diagnostics for gastrointestinal conditions commercial stage san diego ca sprout protedyne acquired by labcorp automation tools for genomics windsor ct sprout radiant medical acquired by zoll proprietary endovascular temperature management systems redwood city ca sprout sapient acquired by webmd portal for consumers with chronic diseases portland or nasdaq hlth sprout selective genetics site specific gene therapeutics and dna devices for tissue repair and regeneration san diego ca sprout sequana therapeutics acquired by axys pharmaceuticals developer of high throughput analytical systems coupled with advanced bioinformatics to decipher the genetic basis of polygenic diseases rockville md sprout sgx pharmaceuticals structure guided drug discovery platform san diego ca nasdaq sgxp sprout sirna therapeutics acquired by merck  co therapeutics based on rna interference rnai san diego ca sprout sopherion therapeutics inc oncology therapeutics clinical stage new haven ct sprout spine wave commercial stage device company marketing novel products for spinal fusion shelton ct sprout spiration acquired by olympus corporation clinical stage device company with novel products targeting diseases of the lung redmond wa sprout spotfire acquired by tibco leading provider of analytical solutions for large datasets somerville ma sprout tripath imaging cytology diagnostics burlington nc nasdaq tpth sprout visiogen acquired by abbott accommodative intraocular lens for the treatment of age related vision loss irvine ca sprout vnus medical technologies devices for treatment of venous disease san jose ca nasdaq vnus intarcia company profile  owler we just sent you an email to verify your account check your inbox     resend verification link  sign in sign in sign up you have just joined